How it works
CMS's final CY 2026 Part D Redesign Program Instructions set three phases: a $615 deductible (100% cash), then 25% coinsurance in the initial coverage phase, until cash out-of-pocket costs hit the $2,100 threshold -- after that, "the enrollee pays no cost sharing for covered Part D drugs" for the rest of the year. The 2026 redesign excludes the Manufacturer Discount Program's contribution from that out-of-pocket count, so brand-name and generic drugs accumulate toward the $2,100 cap at the same rate -- there's no brand-vs-generic wrinkle. At $6,000 of total drug cost you pay $1,961.25 in cash and never reach the cap; at $10,000 you hit the $2,100 cap once your total drug cost reaches $6,555, and the remaining $3,445 of that year's drugs cost nothing. More on the surrounding Medicare choice in the Medicare Advantage vs. Original Medicare guide and the full phase-by-phase math in the Part D drug cost guide.